Maher, T. M., Mayes, M. D., Kreuter, M., Volkmann, E. R., Aringer, M., Castellvi, I., . . . Raghu, G. (2021). Effect of nintedanib on lung function in patients with systemic sclerosis-associated interstitial lung disease: Further analyses of a randomized, double-blind, placebo-controlled trial. Arthritis & rheumatology, 73(4), . https://doi.org/https://doi.org/10.1002/art.41576
Chicago-Zitierstil (17. Ausg.)Maher, Toby M., et al. "Effect of Nintedanib on Lung Function in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-blind, Placebo-controlled Trial." Arthritis & Rheumatology 73, no. 4 (2021). https://doi.org/https://doi.org/10.1002/art.41576.
MLA-Zitierstil (9. Ausg.)Maher, Toby M., et al. "Effect of Nintedanib on Lung Function in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-blind, Placebo-controlled Trial." Arthritis & Rheumatology, vol. 73, no. 4, 2021, https://doi.org/https://doi.org/10.1002/art.41576.